Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Inhibition of Yes-Associated Protein by Verteporfin Ameliorates Unilateral Ureteral Obstruction-Induced Renal Tubulointerstitial Inflammation and Fibrosis

Open access
Jin, Jixiu, Wang, Tian, Park, Woong, Li, Wenjia, Kim, Won, Park, Sung Kwang, Kang, Kyung Pyo · 2020 · International Journal of Molecular Sciences

Abstract

Yes-associated protein (YAP) activation after acute ischemic kidney injury might be related to interstitial fibrosis and impaired renal tubular regeneration. Verteporfin (VP) is a photosensitizer used in photodynamic therapy to treat age-related macular degeneration. In cancer cells, VP inhibits TEA domain family member (TEAD)-YAP interactions without light stimulation. The protective role of VP in unilateral ureteral obstruction (UUO)-induced renal fibrosis and related mechanisms remains unclear. In this study, we investigate the protective effects of VP on UUO-induced renal tubulointerstitial inflammation and fibrosis and its regulation of the transforming growth factor-β1 (TGF-β1)/Smad signaling pathway. We find that VP decreased the UUO-induced increase in tubular injury, inflammation, and extracellular matrix deposition in mice. VP also decreased myofibroblast activation and proliferation in UUO kidneys and NRK-49F cells by modulating Smad2 and Smad3 phosphorylation. Therefore, YAP inhibition might have beneficial effects on UUO-induced tubulointerstitial inflammation and fibrosis by regulating the TGF-β1/Smad signaling pathway.

Overview

Integrity signals

Registry

Crossref · 10.3390/ijms21218184

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Figures

Figure 1 Effect of verteporfin on UUO-induced renal tubular injury and fibrosis. Representative PAS and MTC stains from the kidneys of sham- and UUO-operated mice treated with vehicle (Veh) or verteporfin (VP). Scale bar = 100 µm. Inlet shows a higher magnification view (400×) of UUO 7 d with Veh or VP treatment. The bar graphs show the semi-quantitative scoring of (A) tubular injury stained by PAS and (B) the area fraction (%) of tubulointerstitial fibrosis stained by MTC from ten randomly chosen, non-overlapping fields (n = 10) at a magnification of 200× (n = 15/group). Data are expressed as the mean ± SD. *** p < 0.001 versus Veh or VP; ### p < 0.001 versus UUO. Veh, vehicle; VP, verteporfin; Sham, sham-operated mice; UUO, unilateral ureteral obstruction operated mice.
Figure 1 Effect of verteporfin on UUO-induced renal tubular injury and fibrosis. Representative PAS and MTC stains from the kidneys of sham- and UUO-operated mice treated with vehicle (Veh) or verteporfin (VP). Scale bar = 100 µm. Inlet shows a higher magnification view (400×) of UUO 7 d with Veh or VP treatment. The bar graphs show the semi-quantitative scoring of (A) tubular injury stained by PAS and (B) the area fraction (%) of tubulointerstitial fibrosis stained by MTC from ten randomly chosen, non-overlapping fields (n = 10) at a magnification of 200× (n = 15/group). Data are expressed as the mean ± SD. *** p < 0.001 versus Veh or VP; ### p < 0.001 versus UUO. Veh, vehicle; VP, verteporfin; Sham, sham-operated mice; UUO, unilateral ureteral obstruction operated mice.CC BY · PubMed Central
Figure 2 Effect of verteporfin on UUO-induced renal fibroblast activation. Representative immunofluorescence staining of α-SMA (A) and FPS-1 (B) from the kidneys of sham- and UUO-operated mice treated with vehicle (Veh) or verteporfin (VP). The nuclei were stained with DAPI. The bar graph shows the number of α-SMA and FPS-1 positive cells from ten randomly chosen, non-overlapping fields (n = 10) at a magnification of x400 (n = 15/group). Scale bar = 50 µm. Data are expressed as the mean ± SD. *** p < 0.001 versus Veh or VP; # p < 0.05, ## p < 0.01 versus UUO. α-SMA (C) and Type I collagen (D) expression in kidney tissue from sham and UUO-operated mice treated with Veh or VP was evaluated by Western blotting. Data from the densitometric analysis are presented as the relative ratio of each protein to GAPDH. The relative ratio measured in the kidneys from sham-operated mice treated with Veh is arbitrarily presented as 1. Data are expressed as the mean ± SD. # p < 0.05 versus UUO. Veh, vehicle; VP, verteporfin; UUO, unilateral ureteral obstruction operated mice; α-SMA, α-smooth muscle actin; FSP-1; fibroblast-specific protein-1; DAPI, 4’,6-diamidino-2-phenylindole; GAPDH, glyceraldehyde 3-phosphate dehydrogenase.
Figure 2 Effect of verteporfin on UUO-induced renal fibroblast activation. Representative immunofluorescence staining of α-SMA (A) and FPS-1 (B) from the kidneys of sham- and UUO-operated mice treated with vehicle (Veh) or verteporfin (VP). The nuclei were stained with DAPI. The bar graph shows the number of α-SMA and FPS-1 positive cells from ten randomly chosen, non-overlapping fields (n = 10) at a magnification of x400 (n = 15/group). Scale bar = 50 µm. Data are expressed as the mean ± SD. *** p < 0.001 versus Veh or VP; # p < 0.05, ## p < 0.01 versus UUO. α-SMA (C) and Type I collagen (D) expression in kidney tissue from sham and UUO-operated mice treated with Veh or VP was evaluated by Western blotting. Data from the densitometric analysis are presented as the relative ratio of each protein to GAPDH. The relative ratio measured in the kidneys from sham-operated mice treated with Veh is arbitrarily presented as 1. Data are expressed as the mean ± SD. # p < 0.05 versus UUO. Veh, vehicle; VP, verteporfin; UUO, unilateral ureteral obstruction operated mice; α-SMA, α-smooth muscle actin; FSP-1; fibroblast-specific protein-1; DAPI, 4’,6-diamidino-2-phenylindole; GAPDH, glyceraldehyde 3-phosphate dehydrogenase.CC BY · PubMed Central
Figure 3 Effect of verteporfin on UUO-induced renal inflammation. (A) Representative immunofluorescence staining of F4/80 from the kidneys of sham- and UUO-operated mice treated with vehicle (Veh) or verteporfin (VP). The nuclei were stained with DAPI. The bar graph shows the number of F4/80 positive cells from ten randomly chosen, non-overlapping fields (n = 10) at a magnification of ×400 (n = 15/group). Scale bar = 50 µm. Data are expressed as the mean ± SD. *** p < 0.001 versus Veh or VP; ## p < 0.01 versus UUO. (B) ICAM-1 expression in kidney tissue from sham- and UUO-operated mice treated with Veh or VP was evaluated by Western blotting. Data from the densitometric analysis are presented as the relative ratio of each protein to GAPDH. The relative ratio measured in the kidneys of sham-operated mice treated with Veh is arbitrarily presented as 1. Data are expressed as the mean ± SD. *** p < 0.001 versus Veh or VP; # p < 0.05 versus UUO; Veh, vehicle; VP, verteporfin; Sham, sham-operated mice; UUO, unilateral ureteral obstruction operated mice; ICAM-1, intercellular adhesion molecule-1; DAPI, 4’,6-diamidino-2-phenylindole; GAPDH, glyceraldehyde 3-phosphate dehydrogenase.
Figure 3 Effect of verteporfin on UUO-induced renal inflammation. (A) Representative immunofluorescence staining of F4/80 from the kidneys of sham- and UUO-operated mice treated with vehicle (Veh) or verteporfin (VP). The nuclei were stained with DAPI. The bar graph shows the number of F4/80 positive cells from ten randomly chosen, non-overlapping fields (n = 10) at a magnification of ×400 (n = 15/group). Scale bar = 50 µm. Data are expressed as the mean ± SD. *** p < 0.001 versus Veh or VP; ## p < 0.01 versus UUO. (B) ICAM-1 expression in kidney tissue from sham- and UUO-operated mice treated with Veh or VP was evaluated by Western blotting. Data from the densitometric analysis are presented as the relative ratio of each protein to GAPDH. The relative ratio measured in the kidneys of sham-operated mice treated with Veh is arbitrarily presented as 1. Data are expressed as the mean ± SD. *** p < 0.001 versus Veh or VP; # p < 0.05 versus UUO; Veh, vehicle; VP, verteporfin; Sham, sham-operated mice; UUO, unilateral ureteral obstruction operated mice; ICAM-1, intercellular adhesion molecule-1; DAPI, 4’,6-diamidino-2-phenylindole; GAPDH, glyceraldehyde 3-phosphate dehydrogenase.CC BY · PubMed Central
Figure 4 Effect of verteporfin on UUO-induced connective tissue growth factor expression through the regulation of Smad2 and Smad3 phosphorylation. (A) Phospho-Smad2 and phospho-Smad3 expression in kidney tissue from sham- and UUO-operated mice treated with vehicle (Veh) or verteporfin (VP) was evaluated by Western blotting. Data from the densitometric analysis of phospho-Smad2 and phospho-Smad3 are presented as the relative ratio of each protein to Smad2, Smad3, and GAPDH. The relative ratios measured in the kidneys of sham-operated mice treated with Veh are arbitrarily presented as 1. Data are expressed as the mean ± SD. *** p < 0.001 versus Veh or VP; # p < 0.05 versus UUO. (B) CTGF expression in kidney tissue from sham- and UUO-operated mice treated with Veh or VP was evaluated by Western blotting. Data from the densitometric analysis are presented as the relative ratio of each protein to GAPDH. The relative ratios measured in the kidneys of sham-operated mice treated with Veh are arbitrarily presented as 1. Data are expressed as the mean ± SD. *** p < 0.001 versus Veh or VP; ### p < 0.001 versus UUO; P-Smad, phospho-Smad; CTGF, connective tissue growth factor; Veh, vehicle; VP, verteporfin; UUO, unilateral ureteral obstruction operated mice, GAPDH, glyceraldehyde 3-phosphate dehydrogenase.
Figure 4 Effect of verteporfin on UUO-induced connective tissue growth factor expression through the regulation of Smad2 and Smad3 phosphorylation. (A) Phospho-Smad2 and phospho-Smad3 expression in kidney tissue from sham- and UUO-operated mice treated with vehicle (Veh) or verteporfin (VP) was evaluated by Western blotting. Data from the densitometric analysis of phospho-Smad2 and phospho-Smad3 are presented as the relative ratio of each protein to Smad2, Smad3, and GAPDH. The relative ratios measured in the kidneys of sham-operated mice treated with Veh are arbitrarily presented as 1. Data are expressed as the mean ± SD. *** p < 0.001 versus Veh or VP; # p < 0.05 versus UUO. (B) CTGF expression in kidney tissue from sham- and UUO-operated mice treated with Veh or VP was evaluated by Western blotting. Data from the densitometric analysis are presented as the relative ratio of each protein to GAPDH. The relative ratios measured in the kidneys of sham-operated mice treated with Veh are arbitrarily presented as 1. Data are expressed as the mean ± SD. *** p < 0.001 versus Veh or VP; ### p < 0.001 versus UUO; P-Smad, phospho-Smad; CTGF, connective tissue growth factor; Veh, vehicle; VP, verteporfin; UUO, unilateral ureteral obstruction operated mice, GAPDH, glyceraldehyde 3-phosphate dehydrogenase.CC BY · PubMed Central
Figure 5 Effect of verteporfin on TGF-ß1-induced fibroblast proliferation and cell migration in NRK-49F cells. (A) NRK-49F cells were treated with vehicle (Veh) or TGF-β1 (2 ng/mL) with or without verteporfin (VP) at the indicated doses (50, 100, and 250 nM). After 24 h of treatment, cell proliferation was measured using the XTT assay. Data are expressed as the mean ± SD of three independent experiments performed in triplicate. *** p < 0.001 versus Veh or VP; ### p < 0.001 versus TGF-β1 (2 ng/mL). (B) Representative phase-contrast images of NRK-49F cells after the wound healing assay. The phase-contrast images of the migration of NRK-49F cells into the scratch area were obtained after treatment with either Veh or TGF-β1 (2 ng/mL) with or without VP (250 nM) at 0 h and 24 h after wounding. The bar graph shows the average length by which the gap between the NRK-49F cells closed at 0 h or 24 h after treatment with Veh, TGF-β1, and/or VP. *** p < 0.001 versus Veh or VP; ### p < 0.001 versus TGF-β1. Scale bar = 200 μm. Veh, vehicle; VP, verteporfin; TGF-β1, transforming growth factor-β1.
Figure 5 Effect of verteporfin on TGF-ß1-induced fibroblast proliferation and cell migration in NRK-49F cells. (A) NRK-49F cells were treated with vehicle (Veh) or TGF-β1 (2 ng/mL) with or without verteporfin (VP) at the indicated doses (50, 100, and 250 nM). After 24 h of treatment, cell proliferation was measured using the XTT assay. Data are expressed as the mean ± SD of three independent experiments performed in triplicate. *** p < 0.001 versus Veh or VP; ### p < 0.001 versus TGF-β1 (2 ng/mL). (B) Representative phase-contrast images of NRK-49F cells after the wound healing assay. The phase-contrast images of the migration of NRK-49F cells into the scratch area were obtained after treatment with either Veh or TGF-β1 (2 ng/mL) with or without VP (250 nM) at 0 h and 24 h after wounding. The bar graph shows the average length by which the gap between the NRK-49F cells closed at 0 h or 24 h after treatment with Veh, TGF-β1, and/or VP. *** p < 0.001 versus Veh or VP; ### p < 0.001 versus TGF-β1. Scale bar = 200 μm. Veh, vehicle; VP, verteporfin; TGF-β1, transforming growth factor-β1.CC BY · PubMed Central
Figure 6 Effect of verteporfin on TGF-ß1-induced α-SMA and type I collagen through the regulation of the TGF-β1/Smad signaling pathway in NRK-49F cells. (A) Representative Western blot for α-SMA and type I collagen from NRK-49F cells treated with vehicle (Veh) or TGF-β1 (2 ng/mL) with or without verteporfin (VP) at the indicated doses (50, 100 and 250 nM). Treatment with TGF-β1 (2 ng/mL) for 24 h increased the expression of fibrotic markers. The expression of α-SMA and type I collagen decreased dose-dependently after VP treatment. The bar graph shows the densitometric quantification as the relative ratio of each protein to GAPDH. Data are presented as the mean ± SD. (B) Representative Western blot for phospho-Smad2 and phospho-Smad3 expression from NRK-49F cells treated with vehicle (Veh) or TGF-β1 (2 ng/mL), with or without VP at the indicated doses (50, 100, and 250 nM). TGF-β1 (2 ng/mL) treatment for 30 min increased the expression of phospho-Smad2 and phospho-Smad3, and VP treatment dose-dependently decreased that increase. The densitometric measurement of phospho-Smad2 and phospho-Smad3 protein expression is presented as the Smad2/3 protein expression ratio. The data are represented as the mean ± SD. *** p < 0.001 versus Veh or VP; # p < 0.05, ## p < 0.01 versus TGF-β1 treatment. Veh, vehicle; VP, verteporfin; TGF-β1, transforming growth factor-β1; α-SMA, α-smooth muscle actin; GAPDH, glyceraldehyde 3-phosphate dehydrogenase.
Figure 6 Effect of verteporfin on TGF-ß1-induced α-SMA and type I collagen through the regulation of the TGF-β1/Smad signaling pathway in NRK-49F cells. (A) Representative Western blot for α-SMA and type I collagen from NRK-49F cells treated with vehicle (Veh) or TGF-β1 (2 ng/mL) with or without verteporfin (VP) at the indicated doses (50, 100 and 250 nM). Treatment with TGF-β1 (2 ng/mL) for 24 h increased the expression of fibrotic markers. The expression of α-SMA and type I collagen decreased dose-dependently after VP treatment. The bar graph shows the densitometric quantification as the relative ratio of each protein to GAPDH. Data are presented as the mean ± SD. (B) Representative Western blot for phospho-Smad2 and phospho-Smad3 expression from NRK-49F cells treated with vehicle (Veh) or TGF-β1 (2 ng/mL), with or without VP at the indicated doses (50, 100, and 250 nM). TGF-β1 (2 ng/mL) treatment for 30 min increased the expression of phospho-Smad2 and phospho-Smad3, and VP treatment dose-dependently decreased that increase. The densitometric measurement of phospho-Smad2 and phospho-Smad3 protein expression is presented as the Smad2/3 protein expression ratio. The data are represented as the mean ± SD. *** p < 0.001 versus Veh or VP; # p < 0.05, ## p < 0.01 versus TGF-β1 treatment. Veh, vehicle; VP, verteporfin; TGF-β1, transforming growth factor-β1; α-SMA, α-smooth muscle actin; GAPDH, glyceraldehyde 3-phosphate dehydrogenase.CC BY · PubMed Central

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 44 references

Cited by

See all 45

Metadata

Authors
Jin, J., Wang, T., Park, W., Li, W., Kim, W., Park, S. K., & Kang, K. P.
Affiliations
Jeonbuk National University Hospital (KR)
Corresponding author
  • Park, Sung Kwang
  • Kang, Kyung Pyo
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2020-10-31
Volume
21
Issue
21
Pages
8184
ISSN
1422-0067 (ISSN-L)
OpenAlex
W3095066918
Cited by
43
References
44
Citations by year
2026: 7 · 2025: 7 · 2024: 7 · 2023: 8 · 2022: 8 · 2021: 5 · 2020: 1
FWCI
2.74
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • National Research Foundation of Korea (NRF-2018R1D1A1B07045790, NRF- 2017R1D1A3B03035494)
  • Fund of Biomedical Research Institute, Jeonbuk National University Hospital (CUH2020-0014)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Keywords
verteporfin, YAP, unilateral ureteral obstruction, tubulointerstitial fibrosis, tubulointerstitial inflammation, TGF-β1/Smad signaling, myofibroblast activation, extracellular matrix deposition, acute kidney injury, kidney regeneration
MeSH terms
Verteporfin, YAP-Signaling Proteins, Animals, Cells, Cultured, Disease Models, Animal, Fibrosis, Inflammation, Kidney Diseases, Male, Mice, Inbred C57BL, Ureteral Obstruction, Photosensitizing Agents, Cell Cycle Proteins, Adaptor Proteins, Signal Transducing, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Inhibition of Yes-Associated Protein by Verteporfin Ameliorates Unilateral Ureteral Obstruction-Induced Renal Tubulointerstitial Inflammation and Fibrosis. https://app.cochat.ai/papers/10.3390/ijms21218184
The paper
Jin, J., Wang, T., Park, W., Li, W., Kim, W., Park, S. K., & Kang, K. P. (2020). Inhibition of Yes-Associated Protein by Verteporfin Ameliorates Unilateral Ureteral Obstruction-Induced Renal Tubulointerstitial Inflammation and Fibrosis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms21218184

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.